• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    5/15/25 8:00:17 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $FTLF alert in real time by email
    ftlf20250514_8k.htm
    false 0001374328 0001374328 2025-05-15 2025-05-15
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549 
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of report (Date of earliest event reported): May 15, 2025
     
    Commission File Number: 000-52369
     
    FitLife Brands, Inc.
    (Exact name of registrant as specified in its charter.)
     
    Nevada
    20-3464383
    (State or other jurisdiction of incorporation
    or organization)
    (IRS Employer Identification No.)
     
    5214 S. 136th Street, Omaha, Nebraska 68137
    (Address of principal executive offices)
     
    402-884-1894
    (Registrant's Telephone number)
     
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
    Trading Symbol(s)
    Name of exchange on which registered
    Common Stock, par value $0.01 per share
    FTLF
    Nasdaq Capital Market
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 2.02     Results of Operations and Financial Condition.
     
    On May 15, 2025, FitLife Brands, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended March 31, 2025. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
     
    Item 7.01 Regulation FD Disclosure
     
    See Item 2.02.
     
    Disclaimer.
     
    The information furnished pursuant to Item 2.02 and 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by referenced.
     
    Item 9.01 Financial Statements and Exhibits.
     
    (d) Exhibits Index
     
    Exhibit
    No.
     
    Description
    99.1
     
    Press Release issued by FitLife Brands, Inc., dated May 15, 2025
    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
     
    FitLife Brands, Inc.
         
    Date: May 15, 2025
    By:
    /s/ Dayton Judd
       
    Dayton Judd
     
     
    Get the next $FTLF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FTLF

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    More analyst ratings

    $FTLF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • FitLife Brands Announces First Quarter 2025 Results

      OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

      5/15/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces First Quarter Earnings Call

      OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

      5/5/25 3:00:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Board Transition

      Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

      4/28/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Financials

    Live finance-specific insights

    See more
    • FitLife Brands Announces First Quarter 2025 Results

      OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

      5/15/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces First Quarter Earnings Call

      OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

      5/5/25 3:00:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results

      Omaha, March 27, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the fourth quarter ended December 31, 2024 include: Total revenue was $15.0 million, an increase of 13% compared to the fourth quarter of 2023.  Online sales were $10.1 million, representing 67% of total revenue and an increase of 12% compared to the fourth quarter of 2023.Gross margin was 41.4% compared to 40.3% during the fourth quarter of 2023.Net income was $2.1 million compared to $

      3/27/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Leadership Updates

    Live Leadership Updates

    See more
    • FitLife Brands Announces Board Transition

      Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

      4/28/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • LifeVantage Appoints Dayton Judd to the Board of Directors

      SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

      2/15/24 4:05:00 PM ET
      $FTLF
      $LFVN
      $OPXS
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Electronic Components

    $FTLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:05 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/2/25 8:01:06 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on FitLife Brands with a new price target

      Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

      3/17/25 8:22:47 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • ROTH MKM initiated coverage on FitLife Brands with a new price target

      ROTH MKM initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $40.00

      9/3/24 7:48:49 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    SEC Filings

    See more
    • FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      5/15/25 8:00:17 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 10-Q filed by FitLife Brands Inc.

      10-Q - FITLIFE BRANDS, INC. (0001374328) (Filer)

      5/15/25 7:30:49 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Amendment: SEC Form 10-K/A filed by FitLife Brands Inc.

      10-K/A - FITLIFE BRANDS, INC. (0001374328) (Filer)

      4/28/25 6:43:29 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Hansen Ryan P. claimed ownership of 25,678 shares (SEC Form 3)

      3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      5/12/25 7:27:11 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 3 filed by new insider Pappas Shannon K.

      3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      5/12/25 7:26:27 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care